Turnbridge Capital
2
5M
2
0.15
1
- Stages of investment
- Areas of investment
Summary
In 2008 was created Turnbridge Capital, which is appeared as VC. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Houston.
The usual cause for the fund is to invest in rounds with 2-3 partakers. The meaningful sponsors for the fund in investment in the same round are CB Health Ventures, Burrill & Company, Applied Genomic Technology Capital Funds. In the next rounds fund is usually obtained by Rock Maple Ventures, Morgenthaler Ventures, Forward Ventures.
The common things for fund are deals in the range of 10 - 50 millions dollars. The typical startup value when the investment from Turnbridge Capital is 10-50 millions dollars. The top activity for fund was in 2001. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2007.
Besides them, we counted 4 critical employees of this fund in our database.
We can highlight the next thriving fund investment areas, such as Energy, Manufacturing. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Morphotek For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Rounds per year
- 0.15
- Investments by industry
- Biotechnology (1)
- Innovation Management (1)
- Medical (1)
- Energy (1)
- Renewable Energy (1) Show 1 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 5M
- Group Appearance index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Morphotek | 13 Aug 2001 | Biotechnology, Medical, Innovation Management | Early Stage Venture | 10M | United States, Pennsylvania, Exton |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.